BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25818297)

  • 1. The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation.
    Luo ML; Gong C; Chen CH; Hu H; Huang P; Zheng M; Yao Y; Wei S; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
    Cell Rep; 2015 Apr; 11(1):111-24. PubMed ID: 25818297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
    Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
    Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
    Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
    Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.
    Zhang X; Zhang B; Gao J; Wang X; Liu Z
    J Biol Chem; 2013 Nov; 288(45):32742-32752. PubMed ID: 24072701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
    Rustighi A; Zannini A; Tiberi L; Sommaggio R; Piazza S; Sorrentino G; Nuzzo S; Tuscano A; Eterno V; Benvenuti F; Santarpia L; Aifantis I; Rosato A; Bicciato S; Zambelli A; Del Sal G
    EMBO Mol Med; 2014 Jan; 6(1):99-119. PubMed ID: 24357640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
    Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
    EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolyl isomerase Pin1 in breast development and cancer.
    Wulf G; Ryo A; Liou YC; Lu KP
    Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.
    Rustighi A; Tiberi L; Soldano A; Napoli M; Nuciforo P; Rosato A; Kaplan F; Capobianco A; Pece S; Di Fiore PP; Del Sal G
    Nat Cell Biol; 2009 Feb; 11(2):133-42. PubMed ID: 19151708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shrimp miRNA suppresses the stemness of human cancer stem cells
    Zhang S; Zhang X
    FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
    Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
    Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression.
    Choi HJ; Kim JY; Lim SC; Kim G; Yun HJ; Choi HS
    Br J Pharmacol; 2015 Nov; 172(21):5096-109. PubMed ID: 26267432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
    Suizu F; Ryo A; Wulf G; Lim J; Lu KP
    Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function.
    Rangasamy V; Mishra R; Sondarva G; Das S; Lee TH; Bakowska JC; Tzivion G; Malter JS; Rana B; Lu KP; Kanthasamy A; Rana A
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8149-54. PubMed ID: 22566623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
    Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
    Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.